| Literature DB >> 24214987 |
Ravi Kiran Reddy Kalathur1, José Pedro Pinto, Miguel A Hernández-Prieto, Rui S R Machado, Dulce Almeida, Gautam Chaurasia, Matthias E Futschik.
Abstract
Unified Human Interactome (UniHI) (http://www.unihi.org) is a database for retrieval, analysis and visualization of human molecular interaction networks. Its primary aim is to provide a comprehensive and easy-to-use platform for network-based investigations to a wide community of researchers in biology and medicine. Here, we describe a major update (version 7) of the database previously featured in NAR Database Issue. UniHI 7 currently includes almost 350,000 molecular interactions between genes, proteins and drugs, as well as numerous other types of data such as gene expression and functional annotation. Multiple options for interactive filtering and highlighting of proteins can be employed to obtain more reliable and specific network structures. Expression and other genomic data can be uploaded by the user to examine local network structures. Additional built-in tools enable ready identification of known drug targets, as well as of biological processes, phenotypes and pathways enriched with network proteins. A distinctive feature of UniHI 7 is its user-friendly interface designed to be utilized in an intuitive manner, enabling researchers less acquainted with network analysis to perform state-of-the-art network-based investigations.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24214987 PMCID: PMC3965034 DOI: 10.1093/nar/gkt1100
Source DB: PubMed Journal: Nucleic Acids Res ISSN: 0305-1048 Impact factor: 16.971
Figure 1.Search and result pages in UniHI 7. After performing initial search on the input page, the user is presented with four result pages providing information about detected proteins, physical and regulatory interactions, as well as a graphic network. The user can easily switch between the four pages by clicking on the relevant tab.
Figure 2.Network analysis and visualization tools: (a) original network of the query proteins (GADD45A, SNCA and PARK2); (b) network after filtering based on published evidence (i.e. number of PubMed references ≥3) and with known drug targets highlighted in red; (c) network after filtering with gene expression data (GSE20186) (39). Nodes corresponding to genes with a log2 fold change ≥ +0.2 are displayed in red and those ≤ −0.2 are shown in green; (d) significantly enriched KEGG pathways listed in a table; (e) filtered network with proteins linked to the selected term ‘Neurotrophin signaling pathway’ highlighted in red; and (f) filtered network with proteins linked to ‘Ubiquitin mediated proteolysis’ highlighted in red.